REXTOVY Drug Patent Profile
✉ Email this page to a colleague
When do Rextovy patents expire, and what generic alternatives are available?
Rextovy is a drug marketed by Amphastar Pharms Inc and is included in one NDA.
The generic ingredient in REXTOVY is naloxone hydrochloride. There are twelve drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rextovy
A generic version of REXTOVY was approved as naloxone hydrochloride by HOSPIRA on September 24th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for REXTOVY?
- What are the global sales for REXTOVY?
- What is Average Wholesale Price for REXTOVY?
Summary for REXTOVY
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in REXTOVY? | REXTOVY excipients list |
DailyMed Link: | REXTOVY at DailyMed |
![REXTOVY drug patent expirations Drug patent expirations by year for REXTOVY](/p/graph/s/t/REXTOVY-patent-expirations.png)
Pharmacology for REXTOVY
Drug Class | Opioid Antagonist |
Mechanism of Action | Opioid Antagonists |
US Patents and Regulatory Information for REXTOVY
REXTOVY is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting REXTOVY
NEW PRODUCT
Exclusivity Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amphastar Pharms Inc | REXTOVY | naloxone hydrochloride | SPRAY, METERED;NASAL | 208969-001 | Mar 7, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |